oseltamivir has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Görgülü, Ş; Güleç, K; Kıyan, HT; Yurtdaş-Kırımlıoğlu, G | 1 |
| Abdulkhalek, S; Allison, S; Ellis, JP; Haxho, F; Hrynyk, M; Neufeld, RJ; Steele, JA; Szewczuk, MR | 1 |
2 other study(ies) available for oseltamivir and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay.
Topics: A549 Cells; Acrylic Resins; Angiogenesis Inhibitors; Animals; Apoptosis; Chick Embryo; Chorioallantoic Membrane; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Liberation; Humans; Lung Neoplasms; Nanoparticles; Nanotechnology; Neovascularization, Pathologic; Neovascularization, Physiologic; Oseltamivir; Polyethylene Glycols | 2022 |
Therapeutic designed poly (lactic-co-glycolic acid) cylindrical oseltamivir phosphate-loaded implants impede tumor neovascularization, growth and metastasis in mouse model of human pancreatic carcinoma.
Topics: Absorbable Implants; Angiogenesis Inhibitors; Animals; Antigens, CD; Cadherins; Carcinoma; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Implants; Interleukin Receptor Common gamma Subunit; Liver Neoplasms; Lung Neoplasms; Mice, Inbred NOD; Mice, Knockout; Neovascularization, Pathologic; Oseltamivir; Pancreatic Neoplasms; Platelet Endothelial Cell Adhesion Molecule-1; Polyethylene Glycols; Solubility; Time Factors; Xenograft Model Antitumor Assays | 2015 |